Form D · Biotechnology

PROGENICS PHARMACEUTICALS INC

Tarrytown, NY · CIK 0000835887

Offering snapshot reported Jan 28, 2013 · SEC filing

Reported sold: $12.9M
Investors reported: 11
Minimum accepted: $0
First sale: Jan 18, 2013

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jan 28, 2013	Initial	$12,922,374	No comparison	11	SEC filing
Jan 4, 2006	Paper	Not reported	No comparison	Not reported	SEC filing

Offering details

Securities: Equity
Exemptions: 06
Duration over one year: No
Business combination: Yes

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-190883

Issuer's securities issued for private company stock subject to transfer restrictions. Total offering amount includes up to $93 million in contingent potential milestone payments payable in cash or Issuer's stock, at Issuer's option.

Source: Form D, filed Jan 28, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Mark R. Baker	Director, Executive
Charles A. Baker	Director
Kurt W. Briner	Director
Peter J. Crowley	Director
Stephen P. Goff	Director
Robert J. Israel	Executive
Paul J. Maddon	Director
William C. Olson	Executive
David A. Scheinberg	Director
Nicole S. Williams	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

777 Old Saw Mill River Road
Tarrytown, NY, 10591